TRDA
NASDAQStockEntrada Therapeutics, Inc.
$12.60-0.39 (-2.97%)
52-Week Range
$5.02
$13.50
Key Stats
Market Cap
482.2M
P/E Ratio
—
Dividend Yield
—
Beta
-0.12
Volume
95.7K
Avg Volume
258.2K
Performance
1M
+19.30%
3M
+17.68%
6M
+153.52%
YTD
+29.15%
1Y
+20.07%
3Y
-7.94%
5Y
-45.80%
Price Chart
ETF Exposure
TRDA is held by 54 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| IBRN | iShares Neuroscience and Healthcare ETF | 0.38% |
| HAPS | Harbor Human Capital Factor US Small Cap ETF (HAPS) | 0.17% |
| FSML | Franklin Small Cap Enhanced ETF | 0.13% |
| IWC | iShares Micro-Cap ETF | 0.08% |
| GSSC | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | 0.06% |
| SBIO.L | Invesco NASDAQ Biotech UCITS ETF | 0.04% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.04% |
| AVSC | Avantis U.S. Small Cap Equity ETF | 0.04% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.03% |
| IWN | iShares Russell 2000 Value ETF | 0.03% |
| IBB | iShares Biotechnology ETF | 0.03% |
| NUSC | Nuveen ESG Small-Cap | 0.02% |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | 0.02% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.02% |
| XRS2.DE | Xtrackers Russell 2000 UCITS ETF 1C | 0.01% |
| XRSU.L | Xtrackers Russell 2000 UCITS ETF 1C | 0.01% |
| IWM | iShares Russell 2000 ETF | 0.01% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.01% |
| SC0K.DE | Invesco Russell 2000 UCITS ETF | 0.01% |
| XSU.TO | iShares U.S. Small Cap Index ETF (CAD-Hedged) | 0.01% |
| RSSL | Global X - Russell 2000 ETF | 0.01% |
| VTWO | Vanguard Russell 2000 ETF | 0.01% |
| R2SC.L | State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) | 0.01% |
| UWM | ProShares - Ultra Russell2000 | 0.01% |
| DFAS | Dimensional - US Small Cap ETF | 0.01% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.01% |
| URTY | ProShares - UltraPro Russell2000 | 0.01% |
| DFSV | Dimensional - US Small Cap Value ETF | 0.01% |
| SMMD | iShares Russell 2500 ETF | 0.00% |
| VHT | Vanguard Health Care ETF | 0.00% |
| VXF | Vanguard Extended Market ETF | 0.00% |
| AVSU | Avantis Responsible U.S. Equity ETF | 0.00% |
| HDG | ProShares - Hedge Replication ETF | 0.00% |
| AVUS | Avantis U.S. Equity ETF | 0.00% |
| DFAU | Dimensional - US Core Equity Market ETF | 0.00% |
| IWV | iShares Russell 3000 ETF | 0.00% |
| SCHB | Schwab U.S. Broad Market ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| VUN.TO | Vanguard U.S. Total Market Index ETF | 0.00% |
| VUS.TO | Vanguard U.S. Total Market Index ETF (CAD-hedged) | 0.00% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
Page 1 of 2Next
About TRDA ETF Exposure
Entrada Therapeutics, Inc. (TRDA) is held by 54 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 482.2M, TRDA is a widely held institutional stock. The stock currently trades at $12.60. Investors can gain exposure to TRDA through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold TRDA, sorted by portfolio weight.